What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Shoji Natsugoe focuses on Pathology, Cancer, Metastasis, Internal medicine and Carcinoma.
His Pathology study combines topics from a wide range of disciplines, such as Gene expression and Micrometastasis.
His Cancer study integrates concerns from other disciplines, such as Survival rate, Immune system and Lymph node.
His work deals with themes such as Cancer research, Natural killer cell, Thymidine phosphorylase, Dendritic cell and Tumor progression, which intersect with Metastasis.
The various areas that Shoji Natsugoe examines in his Internal medicine study include Gastroenterology and Oncology.
His Carcinoma study incorporates themes from Esophagus, Cancer cell and Carcinoembryonic antigen.
His most cited work include:
- Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer (380 citations)
- Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. (197 citations)
- Sentinel Node Mapping for Gastric Cancer: A Prospective Multicenter Trial in Japan (188 citations)
What are the main themes of his work throughout his whole career to date?
Shoji Natsugoe spends much of his time researching Internal medicine, Cancer, Pathology, Surgery and Oncology.
His research links Gastroenterology with Internal medicine.
His Cancer research is multidisciplinary, incorporating perspectives in Cancer research and Clinical significance.
His Pathology research includes elements of Lymphovascular invasion and Metastasis.
His studies deal with areas such as Colorectal cancer, Oxaliplatin, Primary tumor and Pancreatic cancer as well as Oncology.
His work deals with themes such as Radiology, Sentinel node, Micrometastasis and Lymph, which intersect with Lymph node.
He most often published in these fields:
- Internal medicine (36.34%)
- Cancer (31.83%)
- Pathology (26.20%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (36.34%)
- Surgery (24.51%)
- Cancer (31.83%)
In recent papers he was focusing on the following fields of study:
Shoji Natsugoe mainly focuses on Internal medicine, Surgery, Cancer, Oncology and Cancer research.
His study in the field of Metastasis, Chemoradiotherapy and Esophageal cancer is also linked to topics like In patient.
As part of his studies on Metastasis, Shoji Natsugoe often connects relevant subjects like Pathology.
The concepts of his Surgery study are interwoven with issues in Colorectal cancer and Esophagectomy.
His studies in Cancer integrate themes in fields like Stage, Chemotherapy and Clinical significance.
His studies deal with areas such as Neoadjuvant therapy, Circulating tumor cell, Survival rate, Liquid biopsy and Primary tumor as well as Oncology.
Between 2016 and 2021, his most popular works were:
- MicroRNA in pancreatic cancer. (72 citations)
- Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. (60 citations)
- Texture analysis of 18 F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy (52 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Internal medicine, Cancer research, Cancer, Surgical oncology and microRNA are his primary areas of study.
Shoji Natsugoe has researched Internal medicine in several fields, including Gastroenterology and Oncology.
His Cancer research research includes elements of Cell, CD44, HMGA2, Oncogene and Pathology.
The various areas that Shoji Natsugoe examines in his Pathology study include Epithelial–mesenchymal transition and Parathyroid disease.
His Cancer study integrates concerns from other disciplines, such as Multivariate analysis and Clinical significance.
His Metastasis study incorporates themes from Pancreatic cancer and Abdominal surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
